Scioderm Garners $16,000,000 Series A Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9f27232f-05a6-4fe9-a4d8-0faf57e027b3 - Date
4/27/2013 - Company Name
Scioderm - Mailing Address
9650 Strickland Road Raleigh, NC 27615 USA - Company Description
The core business focus of Scioderm is the development of innovative dermatological drugs. Our strategy is to in-license or acquire early to mid-stage pharmaceutical products with the intent to develop the topical products. - Website
http://www.sderm.com - Transaction Type
Venture Equity - Transaction Amount
$16,000,000 - Transaction Round
Series A - Proceeds Purposes
With the proceeds from the Series A investment, Scioderm intends to advance SD-101, a topical cream with a unique mechanism of action, into clinical development through registration for the treatment of the severe skin effects seen in patients across all EB subtypes. - M&A Terms
- Venture Investor
- Venture Investor
